Rolf W Sparidans

6PUBLICATIONS
21CO-AUTHORS
Fertilisers (incl. application)Instrumental methods (excl. immunological and bioassay methods)Health and ecological risk assessmentEconometric and statistical methodsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2025
Indoxyl sulfate as a potential tubular function marker across kidney disease models.

Sabbir Ahmed, Shelley X L Chen, Jacqueline P F E Lucas

|Aug 19, 2023
Development and validation of an HPLC-MS/MS method to quantify the KRAS inhibitor adagrasib in mouse plasma and tissue-related matrices.

Irene A Retmana, Nancy H C Loos, Alfred H Schinkel

|Sep 23, 2022
P-Glycoprotein (MDR1/ABCB1) Restricts Brain Accumulation of the Novel EGFR Inhibitor EAI045 and Oral Elacridar Coadministration Enhances Its Brain Accumulation and Oral Exposure.

Jing Wang, M Merve Susam, Changpei Gan

|Jul 20, 2022
Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.

M Merve Susam, Jing Wang, Alfred H Schinkel

|Nov 27, 2021
P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO).

Yaogeng Wang, Rolf W Sparidans, Sander Potters

|Jul 06, 2020
Extrahepatic metabolism of ibrutinib.

Johannes J M Rood, Amer Jamalpoor, Stephanie van Hoppe

Pageof 1

Frequent Collaborators

3 joint publications

Alfred H Schinkel

3 joint publications

Jos H Beijnen

2 joint publications

Rosalinde Masereeuw

1 joint publications

Johannes J M Rood